| Previous Close | 115.170 |
| Open | 115.000 |
| Bid | 115.420 x 100 |
| Ask | 115.670 x 100 |
| Day's Range | 113.713 - 115.920 |
| 52 Week Range | 92.280 - 146.890 |
| Volume | 67,732 |
| Avg. Volume | 71,849 |
| Market Cap | 4.68B |
| Beta | 0.25 |
| PE Ratio (TTM) | 10.45 |
| EPS (TTM) | N/A |
| Earnings Date | N/A |
| Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | N/A |
- Barrons.com•12 days ago
[$$] In Hot Pursuit of Indian Growth Stocks
Former police superintendent Sunil Asnani is on the patrol for growth stocks in India. Prior to managing Matthews Asia’s $130 million India strategy, Asnani worked on the beat in the southern Indian state of Kerala. The market is one of Asia’s priciest, while there are concerns about corporate governance and bad assets in the banking system persist.
- Capital Cube•13 days ago
ETFs with exposure to Taro Pharmaceutical Industries Ltd. : July 12, 2017
Categories: ETFs Yahoo FinanceClick here to see latest analysis ETFs with exposure to Taro Pharmaceutical Industries Ltd. Here are 5 ETFs with the largest exposure to TARO-US. Comparing the performance and risk of Taro Pharmaceutical Industries Ltd. with the ETFs that have exposure to it gives us some ETF choices that could give us similar returns with lower ... Read more (Read more...)
- Capital Cube•28 days ago
ETFs with exposure to Taro Pharmaceutical Industries Ltd. : June 27, 2017
Categories: ETFs Yahoo FinanceClick here to see latest analysis ETFs with exposure to Taro Pharmaceutical Industries Ltd. Here are 5 ETFs with the largest exposure to TARO-US. Comparing the performance and risk of Taro Pharmaceutical Industries Ltd. with the ETFs that have exposure to it gives us some ETF choices that could give us similar returns with lower ... Read more (Read more...)
